Wang, S., Khullar, K., Kim, S., Yegya-Raman, N., Malhotra, J., Groisberg, R., . . . Jabbour, S. K. (2020). Effect of cyclo-oxygenase inhibitor use during checkpoint blockade immunotherapy in patients with metastatic melanoma and non-small cell lung cancer. J Immunother Cancer.
Chicago Style CitationWang, Shang-Jui, et al. "Effect of Cyclo-oxygenase Inhibitor Use During Checkpoint Blockade Immunotherapy in Patients With Metastatic Melanoma and Non-small Cell Lung Cancer." J Immunother Cancer 2020.
Cita MLAWang, Shang-Jui, et al. "Effect of Cyclo-oxygenase Inhibitor Use During Checkpoint Blockade Immunotherapy in Patients With Metastatic Melanoma and Non-small Cell Lung Cancer." J Immunother Cancer 2020.
Atenció: Aquestes cites poden no estar 100% correctes.